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More Reﬂective of Moral Integrity Than RulesValentin Fuster, MD, PHDO ver the past several decades, there has beena concerted effort for health care systems,professional societies, and medical peer-
reviewed journals to establish policies that require
caregivers and authors to declare “relationships”
with industry (1). This Editor’s Page will not focus
on the policies themselves or their effectiveness.
Rather, I wish to reﬂect for a few minutes as a cardi-
ologist, as a cardiovascular investigator, and as an
educator. These disclosures with industry or others,
in my opinion, always come down to our own moral
integrity. It is our obligation to be honest about what-
ever conﬂicts cause us to be biased—and those biases
may not only originate with industry. Importantly, it is
our responsibility not to become conﬂicted in a way
that impairs our clinical decision-making or our judg-
ments about research.
Considerable attention has been focused on the
effect that “relationships with industry” have on an
investigator’s objectivity when conducting research
and on the subsequent publications that result
from those analyses. One survey of faculty (1,156
respondents) at 33 U.S. medical schools sought to
assess how industry sponsorship and involvement
with research affects the individual investigators (2).
Although they wrote that relationships with industry
were important to conducting research, the authors
reported that a signiﬁcant number of the respondents
who receive industry support noted compromises
to research initiatives (economic or otherwise)
(35%), to publication (28%), to interpretation of data
(25%), or to overall scientiﬁc advancement (20%) (2).
These types of ﬁndings and additional speculation
about such inﬂuence have led nearly all heath
care providers and medical journals to establish. Wiener Cardiovascular Institute, Icahn
inai, New York, New York.policies that seek to add transparency to these
relationships. Speciﬁcally, in hopes of distancing
themselves from any potential relationship with in-
dustry, some journals have instituted policies so
stringent that they have limited their access to expert
reviewers and authors—forcing them to later reverse
those policies (3).
While these policies originated with the proper
intentions, I am proposing they can do little to
eliminate deep-seated, personal biases. For example,
from the context of the editor, bias—whether in-
dustry or not—in the peer review process can take
on various forms, including prestige, nationality,
language, sex, or the most prevalent, content-based
biases. Content-based bias involves partiality for or
against a submission by virtue of the content (e.g.,
methods, theoretical orientation, or results) of the
work (4). When content experts are selected to serve
as reviewers on a paper that contradicts their own
research pathways or clinical understanding, they
are either going to embrace the integrity that they
should and assess the manuscript impartially or
oppose it without even examining the work. Unfor-
tunately, there is no policy or disclosure form that
will liberate our profession from this type of biased
predisposition. With this understanding, the JACC
associate editors and I often have to consider the
potential bias of the reviewers in our decision-
making. Psychological research has shown that
some biases are so ingrained that they are subcon-
scious (5).
Medical journals are not the only bastions of sci-
ence that have to contend with these considerations.
In my experience, scientiﬁc committees—which are
often tasked with guiding research and practice and
are bound to the same moral standards—may contain
considerable biases, even if the individuals are not
involved with industry relationships. The reason that
industry relationship disclosures have become the
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2458gold standard is because they are quantiﬁable, but the
type of personal bias about which I am speaking is not
quantiﬁable, and in my opinion, may be far more
pernicious to the purity of medical research and
clinical practice.
Based on my lifetime experience with journals and
committees, there is a nonquantiﬁable bias that is
unrelated to industry. Amid this scrutiny, we cannot
forget that industry remains an integral partner in
clinical practice and research—and does not neces-
sarily have to bias the individual, if the person
maintains his or her moral personal integrity. Again,
the purpose of this Editor’s Page is to partake inan unwritten agreement with the fellow clinicians,
investigators, and educators: we need to seek
contentment in our lives and life choices, and once
we do, we must remember and prioritize our moral
integrity and commitment to the betterment of pa-
tients (6). From this objective, it is much easier not to
be overtaken by bias.
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